Siyang Liu

321 Zhongshan Rd
Nanjing, 210008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Inert Complexes Unlock Ligand-Accelerated Transition-Metal Catalysis on Proteins.

Inert Complexes Unlock Ligand-Accelerated Transition-Metal Catalysis on Proteins.

Journal: Angewandte Chemie (International ed. in English)

Published: November 13, 2025

A COX-2-Targeted Platinum(lV) Prodrug Induces Apoptosis and Reduces Inflammation in Bladder Cancer Models.

A COX-2-Targeted Platinum(lV) Prodrug Induces Apoptosis and Reduces Inflammation in Bladder Cancer Models.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 07, 2025

Single-Cell Multiomics Identifies Glycan Epitope LacNAc as a Potential Cell-Surface Effector Marker of Peripheral T Cells in Bladder Cancer Patients.

Single-Cell Multiomics Identifies Glycan Epitope LacNAc as a Potential Cell-Surface Effector Marker of Peripheral T Cells in Bladder Cancer Patients.

Journal: ACS chemical biology

Published: November 25, 2024

Plasma tsRNA Signatures Serve as a Novel Biomarker for Bladder Cancer.

Plasma tsRNA Signatures Serve as a Novel Biomarker for Bladder Cancer.

Journal: Cancer science

Published: September 19, 2024

Evaluation of Multispecific Drugs Based on Patient-Derived Immunocompetent Tumor Organoids.

Evaluation of Multispecific Drugs Based on Patient-Derived Immunocompetent Tumor Organoids.

Journal: Chembiochem : a European journal of chemical biology

Published: September 05, 2024

Patient-derived Immunocompetent Tumor Organoids: A Platform for Chemotherapy Evaluation in the Context of T-cell Recognition.

Patient-derived Immunocompetent Tumor Organoids: A Platform for Chemotherapy Evaluation in the Context of T-cell Recognition.

Journal: Angewandte Chemie (International ed. in English)

Published: November 19, 2023

ALOX5 deficiency contributes to bladder cancer progression by mediating ferroptosis escape.

ALOX5 deficiency contributes to bladder cancer progression by mediating ferroptosis escape.

Journal: Cell death & disease

Published: August 31, 2023

The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer.

The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer.

Journal: Frontiers in immunology

Published: November 26, 2022

Prediction of immune infiltration and prognosis for patients with urothelial bladder cancer based on the DNA damage repair-related genes signature.

Prediction of immune infiltration and prognosis for patients with urothelial bladder cancer based on the DNA damage repair-related genes signature.

Journal: Heliyon

Published: May 22, 2022

Syngeneic bone marrow transplantation in combination with PI3K inhibitor reversed hyperglycemia in later-stage streptozotocin-induced diabetes.

Syngeneic bone marrow transplantation in combination with PI3K inhibitor reversed hyperglycemia in later-stage streptozotocin-induced diabetes.

Journal: Annals of translational medicine

Published: June 28, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026